All FDA-approved EMA-approved PMDA-approved
Target Card Uniprot Example: P23975

emetine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definition	Drug id	CAS RN
	1001	483-18-1

Description:

Molecule

Description

Molfile Inchi Smiles Synonyms: emetine dihydrochloride emetine hydrochloride methylcephaeline ipecine emetine (-)-Emetine cephaeline methyl ether emetin

The principal alkaloid of ipecac, from the ground roots of Uragoga (or Cephaelis) ipecacuanha or U. acuminata, of the Rubiaceae. It is used as an amebicide in many different preparations and may cause serious cardiac, hepatic, or renal damage and violent diarrhea and vomiting. Emetine inhibits protein synthesis in EUKARYOTIC CELLS but not PROKARYOTIC CELLS. Molecular weight: 480.65 Formula: C29H40N2O4 CLOGP: 4.75 LIPINSKI: 0 HAC: 6 HDO: 1 TPSA: 52.19 ALOGS: -5.23 ROTB: 7

Drug dosage:

Dose	Unit	Route
60	mg	P

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

Property	Description	Value	Unit	Confidence	Similarity
azlogd74	LogD at pH 7.4	0.442		Moderate	0.75
caco2-efflux	Caco-2 efflux ratio (BA/AB)	10.139		Moderate	0.75
caco2-intrinsic-papp	Caco-2 intrinsic apparent permeability	2.483	10^-6 cm/s	Moderate	0.75
dh-clint	Dog hepatocyte intrinsic clearance	3.228	uL/min/10^6 cells	Moderate	0.75
dppb	Dog plasma protein binding (% unbound)	60.220	%	Moderate	0.75
fcs-ppb	Fetal calf serum protein binding (% unbound)	63.310	%	Moderate	0.75
herg	hERG pIC50	4.827	pIC50	Moderate	0.75
hh-clint	Human hepatocyte intrinsic clearance	1.679	uL/min/10^6 cells	Moderate	0.75
hlm-clint	Human liver microsomal intrinsic clearance	6.823	uL/min/mg protein	Moderate	0.75
hppb	Human plasma protein binding (% unbound)	64.010	%	Moderate	0.75
kinase-safety-class	ACVR2A,ACVR2B,AKT2,AKT3,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,ITK,JAK2,JAK3,MAP3K21,MAP3K7,MAPK10,MAPK7,MAPKAPK2,MET,MTOR,NTRK2,PDK2,PDK4,PDPK1,PIK3CB,PIM2,PRKCD,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ZAP70	46
kinase-selectivity-class	AKT3,AXL,EIF2AK3,EPHB4,ERBB2,GRK2,MET,PDK4,PRKDC,SIK2,TTK	11
mdck-mdr1-efflux	MDCK-MDR1 efflux ratio	2.938		Moderate	0.75
mh-clint	Mouse hepatocyte intrinsic clearance	17.906		Moderate	0.75
mppb	Mouse plasma protein binding (% unbound)	51.550		Moderate	0.75
nih-mdck-mdr1-efflux	NIH MDCK-MDR1 efflux ratio	9.204		Moderate	0.75
pfas-class	PFAS structural alert (1 = True, 0 = False)	0
pppb	Pig plasma protein binding (% unbound)	74.030	%	Moderate	0.75
rh-clint	Rat hepatocyte intrinsic clearance	10.139	uL/min/10^6 cells	Moderate	0.75
rh-fuinc	Rat hepatocyte fraction unbound in incubation	76.140	%	Moderate	0.75
rppb	Rat plasma protein binding (% unbound)	57.770	%	Moderate	0.75
solubility-dd	Solubility at pH 7.4 in DMSO	845.279	uM	Moderate	0.75

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	P01AX02	ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS ANTIPROTOZOALS AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES Other agents against amoebiasis and other protozoal diseases
ATC	P01AX52	ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS ANTIPROTOZOALS AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES Other agents against amoebiasis and other protozoal diseases
MeSH PA	D000563	Amebicides
MeSH PA	D000871	Anthelmintics
MeSH PA	D000890	Anti-Infective Agents
MeSH PA	D000969	Antinematodal Agents
MeSH PA	D000977	Antiparasitic Agents
MeSH PA	D000981	Antiprotozoal Agents
MeSH PA	D002400	Cathartics
MeSH PA	D004639	Emetics
MeSH PA	D004791	Enzyme Inhibitors
MeSH PA	D005765	Gastrointestinal Agents
MeSH PA	D011500	Protein Synthesis Inhibitors
CHEBI has role	CHEBI:22587	antiviral agent
CHEBI has role	CHEBI:35441	antiinfective agent
CHEBI has role	CHEBI:35610	antineoplastic agent
CHEBI has role	CHEBI:35820	antiprotozoal drug
CHEBI has role	CHEBI:38068	antimalarial
CHEBI has role	CHEBI:48001	protein synthesis inhibitor
CHEBI has role	CHEBI:76924	plant metabolite
CHEBI has role	CHEBI:77035	expectorant
CHEBI has role	CHEBI:88230	autophagy inhibitor
CHEBI has role	CHEBI:149552	emetic
CHEBI has role	CHEBI:149553	anticoronaviral agent
CHEBI has role	CHEBI:171664	antiamoebic agent

Related Drugs by ATC class:

P01AX Other agents against amoebiasis and other protozoal diseases 9 drugs

atovaquonechiniofondihydroemetinefumagillinmepacrinenitazoxanidephanquinonetenonitrozoletrimetrexate

Drug Use | Suggest Off label Use Form| |View source of the data|

None

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation level	Dissociation constant	Type (acidic/basic)
pKa1	11.4	Basic
pKa2	9.01	Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

Target	Class	Pharos	UniProt	Action	Type	Activity value (-log[M])	Mechanism action	Bioact source	MoA source
Alpha-2A adrenergic receptor	GPCR	P08913	ADA2A_HUMAN		Ki	7.85		DRUG MATRIX
Alpha-2C adrenergic receptor	GPCR	P18825	ADA2C_HUMAN		Ki	7.59		DRUG MATRIX
Alpha-1D adrenergic receptor	GPCR	P25100	ADA1D_HUMAN		Ki	5.58		DRUG MATRIX
Putative hydrolase RBBP9	Enzyme	O75884	RBBP9_HUMAN		IC50	5.11		CHEMBL
Alpha-1B adrenergic receptor	GPCR		ADA1B_RAT		Ki	5.97		DRUG MATRIX
Alpha-1A adrenergic receptor	GPCR		ADA1A_RAT		IC50	5.19		CHEMBL
NS5	Enzyme		A0A143MHK7_ZIKV		EC50	8.06		CHEMBL

External reference:

ID	Source
4019743	VUID
N0000147834	NUI
316-42-7	SECONDARY_CAS_RN
4017461	VANDF
4019743	VANDF
C0013974	UMLSCUI
CHEBI:4781	CHEBI
34G	PDB_CHEM_ID
CHEMBL50588	ChEMBL_ID
CHEMBL493439	ChEMBL_ID
D004640	MESH_DESCRIPTOR_UI
DB13393	DRUGBANK_ID
11087	IUPHAR_LIGAND_ID
X8D5EPO80M	UNII
10219	PUBCHEM_CID
3820	RXNORM
002953	NDDF
004874	NDDF
12290003	SNOMEDCT_US
12559001	SNOMEDCT_US
373466009	SNOMEDCT_US
X8D5EPO80M	INXIGHT DRUGS

Pharmaceutical products:

None